Withanolide compound as well as preparation method and application thereof
A technology for ester compounds and ashwagandha, which is applied in the field of ashwagandha lactones and their preparation, can solve the problems of normal cytotoxicity of ashwagandha lactone compounds without antitumor activity reported in the literature, and achieves significant inhibitory activity, saving Production cost, the effect of novel structure
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0065] Embodiment 1: the preparation of formula (Ia) compound
[0066] (1) Extraction: Dragon Ball medicinal material (dried whole herb of Dragon Ball) is ground into coarse powder. Take 4 kg of coarse powder of Dragon Ball medicinal material, add appropriate amount of 95% ethanol to cold soak for 24 hours, then extract by percolation, and collect percolation liquid. The volume of the total solvent extracted is equivalent to 20 times of the quality of the medicinal material (a total of 80 L of 95% ethanol is used).
[0067] (2) Extraction: Concentrate the percolation liquid obtained in step (1) under reduced pressure until it has no alcohol smell, add water to suspend the obtained extract to about 1.6L, extract with 1.6L of ethyl acetate, extract 4 times, and combine the extracts , to obtain the Dragon Ball ethyl acetate extract. The solvent was recovered under reduced pressure and concentrated to obtain 116.15 g of dragon pearl ethyl acetate extract.
[0068] (3) Normal-ph...
Embodiment 2
[0070] Embodiment 2: the structural identification of the formula (Ia) compound that embodiment 1 makes:
[0071] Take about 7.8 mg of the compound, and use CDCl 3 dissolve, test its 1 H NMR spectrum, 13 C NMR spectrum, 2D NMR spectrum; Take an appropriate amount of compound to test its HR-MS spectrum, IR spectrum, and test its specific rotation.
[0072] figure 2 It is the proton nuclear magnetic resonance spectrum of the compound of formula (Ia) structure of the present invention.
[0073] image 3 It is the carbon nuclear magnetic resonance spectrum of the compound of the formula (Ia) structure of the present invention.
[0074] Figure 4 is the DEPT spectrum of the compound of formula (Ia) structure of the present invention.
[0075] Figure 5 Is the compound of formula (Ia) structure of the present invention 1 H- 1 H CSOY spectrum.
[0076] Figure 6 is the HSQC spectrum of the compound of formula (Ia) structure of the present invention.
[0077] Figure 7 ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


